Open Access

Erratum: Identification of novel RHPS4-derivative ligands with improved toxicological profiles and telomere-targeting activities

  • Angela Rizzo1,
  • Sara Iachettini1,
  • Pasquale Zizza1,
  • Chiara Cingolani1,
  • Manuela Porru1,
  • Simona Artuso1,
  • Malcolm Stevens2,
  • Marc Hummersone3,
  • Annamaria Biroccio1,
  • Erica Salvati1Email author and
  • Carlo Leonetti1Email author
Contributed equally
Journal of Experimental & Clinical Cancer Research201534:9

https://doi.org/10.1186/s13046-014-0101-x

Received: 18 November 2014

Accepted: 18 November 2014

Published: 5 February 2015

The original article was published in Journal of Experimental & Clinical Cancer Research 2014 33:81

Erratum

After the publication of this article [1] the authors noticed an error in the Acknowledgements section. The corrected Acknowledgments is included below. The authors apologise for any inconvenience.

Notes

Declarations

Acknowledgements

Costs of experiments described within this manuscript were funded by Pharminox Ltd. The costs of the biological experiments were funded by Italian Association for Cancer Research (AIRC#11567 to A.B. and AIRC #14337 to C.L). Dr. A. Rizzo and E. Salvati are recipient of fellowships from the Veronesi Foundation.

We wish to thank Dr. I. Hutchinson, Dr. Marc Geoffrey Hummersone, Dr D. Cousin and Dr. M. Frigerio for the synthesis of the new compounds 210.

Authors’ Affiliations

(1)
Experimental Chemotherapy Laboratory, Regina Elena National Cancer Institute
(2)
School of Pharmacy, University of Nottingham
(3)
Pharminox Ltd, Biocity, Pennyfoot St

Reference

  1. Rizzo, et al. Identification of novel RHPS4-derivative ligands with improved toxicological profiles and telomere-targeting activities. J Exp Clin Cancer Res. 2014;33:81.View ArticlePubMed CentralPubMedGoogle Scholar

Copyright

© Rizzo et al.; licensee BioMed Central. 2015

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Advertisement